Diabetic control and atypical antipsychotics: a case report
<p>Abstract</p> <p>Introduction</p> <p>People with schizophrenia are at increased risk of developing metabolic disturbances. This risk may be further exacerbated by the use of antipsychotic agents. Research is still ongoing to determine the metabolic impact of antipsych...
Main Authors: | Gaston Romina, George Mohan, Azhahan Nangai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-05-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/2/1/155 |
Similar Items
-
Diabetes and atypical antipsychotics
by: Stathaki Maria, et al.
Published: (2008-04-01) -
Atypical antipsychotics:
by: Claudia Aparecida Avelar Ferreira, et al.
Published: (2015-10-01) -
Asenapine: an atypical antipsychotic with atypical formulations
by: Meghan Musselman, et al.
Published: (2021-09-01) -
Atypical antipsychotics, more than just an antipsychotic
by: Hiram Tendilla-Beltran, et al.
Published: (2020-01-01) -
Use of atypical antipsychotics and risk of hypertension: A case report and review literature
by: Beatriz Beretta Alves, et al.
Published: (2019-04-01)